Stock screener

ANGO

Conviction 85HealthcareScan · Thu, Sep 24, 2026

Angiodynamics Inc (ANGO) closed at $15.29 (-1.42%) on Sep 24, 2026. Price is above its 50-day and above its 200-day moving average. RSI(14) 47, RS Rating 88, -5.2% from its 52-week high, +20.6% year to date. Sector: Healthcare · SURGICAL & MEDICAL INSTRUMENTS & APPARATUS.

ANGO$15.29-1.42%
ResistanceSupportVol 14Congress buyCongress sell
63 bars
Vol MA14 486.09K
Jun 26Jul 15Aug 3Aug 19Sep 8Sep 24
ANGIODYNAMICS INCSURGICAL & MEDICAL INSTRUMENTS & APPARATUSwww.angiodynamics.com ↗
Price15.29
Change-1.42%
Gap+0.52%
Rel volume1.41×
Avg volume432.38K
Avg $ vol6.7M
SMA 2015.52
SMA 5015.21
SMA 20012.41
Price vs 50+0.54%
Price vs 200+23.16%
MA stackbullish
50/200 cross—
Supertrendup · 14.66
RSI (14)47
MACD hist-0.05
MACD cross—
Stoch %K / %D41 / 54
ADX (14)15
+DI / −DI15 / 16
RSI divergence—
MACD divergence—
ATR %3.12%
ADR %3.08%
52w high16.13
52w low9.70
From 52w high-5.21%
Above 52w low+57.63%
New 52w highNo
SqueezeOn · 8d
Bollinger width6.30%
%B0.27
Donchian pos30.56%
Donchian high16.29
Donchian low14.85
AVWAP (52w high)15.52
vs AVWAP high-1.49%
AVWAP (52w low)13.30
vs AVWAP low+15.00%
OBV trendFlat
Chaikin MF (20)0.10
Today vs 20d1.41×
Avg vol (14d)486.09K
Avg vol (20d)432.38K
Avg $ vol (20d)6.7M
Market cap631.97M
RS Rating88 / 99
RS 3m (vs SPY)+7.44%
RS 6m (vs SPY)+19.46%
RS line new highNo
Trend template8/8
Technical rank78.8
1 week-0.52%
1 month-4.14%
3 months+11.93%
6 months+36.27%
1 year+41.71%
YTD+20.58%
P/E-17.20
P/B3.70
P/S1.97
P/FCF1244.04
EPS-0.8800
Div yield—
ROE-21.51%
ROA-13.75%
Debt/Eq0.73
Current2.19
EV/EBITDA-41.39
Gross margin54.62%
Net margin-11.48%
Rev growth9.46%
EPS growth-8.09%
Price target21.00
Target upside37.34%
Analyst ratingBuy
Institutional102.53%
Ent. value702.52M
Revenue78.42M
Net income-8.08M
Gross profit41.48M
Free cash flow508K
IndustrySURGICAL & MEDICAL INSTRUMENTS & APPARATUS
ExchangeNasdaq
Shares out41.32M
Employees675
ListedThu, May 27, 2004
Free float38.65M
Float %93.8%
Short interest1.36M
Days to cover5.4d
Short volume25.5%
Squeeze score38 / 100
Next earnings—
EPS forecast—
Last EPS vs est−$0.07 vs −$0.11
Last surprise+36.4% beat
Setup gradeA+
Conviction85 / 100
Pattern quality—
Tech rank78.8 / 100
Group rank59 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance16.23
Support14.91
Days since event—
Candle confirm—

Financials as of Sat, Feb 28, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in ANGO · 4 recent

All disclosures →
MemberSideAmount
Debbie Wasserman Schultz
Debbie Wasserman Schultz
house · D · FL · traded 2025-10-20
Sell≥ $2K
Debbie Wasserman Schultz
Debbie Wasserman Schultz
house · FL · traded 2025-10-20
Sell≥ $2K
Debbie Wasserman Schultz
Debbie Wasserman Schultz
house · D · FL · traded 2025-06-27
Buy$1K–$15K
Debbie Wasserman Schultz
Debbie Wasserman Schultz
house · D · FL · traded 2025-07-16
Sell$1K–$15K

Insider activity

SEC Form 4 transactions in ANGO

InsiderSideShares
Weiss Lawrence T
SVP, Chief Legal Officer · Common Stock · 2026-07-15
Grant21.29K
Weiss Lawrence T
SVP, Chief Legal Officer · Performance Right · 2026-07-15
Grant21.29K
Campbell Chad Thomas
SVP/GM, Vascular Access · Common Stock · 2026-07-15
Grant16.08K
Campbell Chad Thomas
SVP/GM, Vascular Access · Performance Right · 2026-07-15
Grant16.08K
Nighan Warren JR
SVP Quality and Regulatory · Common Stock · 2026-07-15
Grant17.97K
Nighan Warren JR
SVP Quality and Regulatory · Performance Right · 2026-07-15
Grant17.97K
Piccinini Laura
SVP International · Common Stock · 2026-07-15
Grant19.86K
Piccinini Laura
SVP International · Performance Right · 2026-07-15
Grant19.86K
Trowbridge Stephen A
EVP and CFO · Common Stock · 2026-07-15
Grant53.26K
Trowbridge Stephen A
EVP and CFO · Performance Right · 2026-07-15
Grant53.26K

SEC filings

EDGAR filings in ANGO · 3 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.